Paying for Performance and CE of Strategies to Combat Anemia in China

中国抗击贫血战略的绩效和CE支付

基本信息

  • 批准号:
    8026425
  • 负责人:
  • 金额:
    $ 62.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-15 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): An important explanation for limited global health program effectiveness is behavioral obstacles that drive a wedge between the laboratory efficacy of health technologies and their effectiveness in real-world programs. Innovative new forms of contracting that address these behavioral obstacles by rewarding both providers (on the supply-side) and consumers (on the demand-side) for ultimate social objectives like good health outcomes may therefore produce large health gains in developing countries. There is a paucity of rigorous evidence on their actual benefits in practice, however. The proposed project will produce several important advances over previous studies of pay-for- performance incentives. First, existing evidence from the handful of good-quality studies provides limited insight into the full promise of pay-for-performance incentives because they reward the use of specific health inputs rather than actual health improvement. Rewarding health outcomes directly (as we propose to do) provides stronger incentives for providers and consumers to use local information to develop innovative new health improvement strategies without rigidly prescribing about how they should do so. Second, although knowledge about the impact of demand-side incentives has recently grown, there is no evidence on their comparative effectiveness (and cost-effectiveness) relative to supply-side incentives. Third, whether or not demand- and supply-side incentives are net substitutes or complements - a key question for policymakers combining different interventions into large-scale health improvement strategies - is completely unknown. To provide new evidence on how better to align supply-side incentives with good population health and to assess their comparative effectiveness and potential synergies with demand-side incentives, we propose to conduct a large-scale randomized policy experiment in rural China. Our specific focus is the provision of incentives for reducing anemia to primary school principals and the parents of their students. Our project is the first of which we are aware that directly rewards health outcomes, and it holds the potential for immediate impact given current interest from China's government. In doing so, we propose six specific aims: (1) To provide new estimates of anemia prevalence among primary school age children in rural China; (2) To analyze the behavioral responses of educators (principals) in poor rural primary schools in China to pay-for-performance rewards for reducing anemia - and their net health consequences; (3) To estimate how private health investments that parents make in their children respond to public health interventions; (4) To study the comparative effectiveness of supply- and demand-side incentives for anemia reduction and to assess whether or not they are net complements or substitutes; (5) To calculate the cost-effectiveness of supply- and demand-side approaches for anemia reduction; and (6) To create a new, publicly available dataset of rural Chinese children and their schools. PUBLIC HEALTH RELEVANCE: This project studies the effectiveness of different behavioral strategies to reduce anemia in resource-limited settings. It will therefore provide new evidence about behavioral approaches to increasing the use of public health technologies with known efficacy.
描述(由申请人提供):全球卫生计划有效性有限的一个重要解释是行为障碍,这些障碍在卫生技术的实验室效率和它们在现实世界计划中的有效性之间造成了分歧。因此,创新的新合同形式通过奖励提供者(在供应方)和消费者(在需求方)实现最终的社会目标,如良好的健康结果,来解决这些行为障碍,可能会在发展中国家产生巨大的健康收益。然而,关于它们在实践中的实际好处,缺乏严格的证据。拟议的项目将比以前对绩效工资激励的研究产生几个重要的进步。首先,来自少数高质量研究的现有证据对按绩效支付激励的全部承诺提供了有限的洞察力,因为它们奖励使用特定的健康投入,而不是实际的健康改善。直接奖励健康结果(正如我们提议的那样)为提供者和消费者提供了更强的激励,促使他们利用当地信息制定创新的新健康改善战略,而不是硬性规定他们应该如何做到这一点。其次,尽管对需求侧激励的影响的了解最近有所增加,但没有证据表明它们相对于供应侧激励的相对有效性(和成本效益)。第三,需求和供应方面的激励是净替代还是互补--这是政策制定者将不同干预措施结合到大规模健康改善战略中的一个关键问题--是完全未知的。为了为如何更好地将供给侧激励与良好的人口健康相结合提供新的证据,并评估其与需求侧激励的比较有效性和潜在的协同效应,我们建议在农村中国进行一项大规模的随机政策试验。我们的具体重点是向小学校长及其学生家长提供减少贫血症的奖励。我们的项目是我们意识到的第一个直接回报健康结果的项目,考虑到中国政府目前的兴趣,它有可能产生直接影响。为此,我们提出了六个具体目标:(1)提供对中国农村小学适龄儿童贫血患病率的新估计;(2)分析中国农村贫困小学教师(校长)对减少贫血的绩效奖励及其净健康后果的行为反应;(3)估计父母对子女的私人卫生投资对公共卫生干预的反应;(4)研究供给侧和需求侧激励措施对减少贫血的比较有效性,并评估它们是否是净补充或替代;(5)计算减少贫血的供给侧和需求侧方法的成本效益;以及(6)创建一个新的、可公开获得的中国农村儿童及其学校的数据集。 公共卫生相关性:该项目研究在资源有限的环境中减少贫血的不同行为策略的有效性。因此,它将提供有关行为方法的新证据,以增加对已知有效性的公共卫生技术的使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Norman G Miller其他文献

Norman G Miller的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Norman G Miller', 18)}}的其他基金

Paying for Performance and CE of Strategies to Combat Anemia in China
中国抗击贫血战略的绩效和CE支付
  • 批准号:
    8476265
  • 财政年份:
    2011
  • 资助金额:
    $ 62.84万
  • 项目类别:
Paying for Performance and CE of Strategies to Combat Anemia in China
中国抗击贫血战略的绩效和CE支付
  • 批准号:
    8653004
  • 财政年份:
    2011
  • 资助金额:
    $ 62.84万
  • 项目类别:
Paying for Performance and CE of Strategies to Combat Anemia in China
中国抗击贫血战略的绩效和CE支付
  • 批准号:
    8819558
  • 财政年份:
    2011
  • 资助金额:
    $ 62.84万
  • 项目类别:
Paying for Performance and CE of Strategies to Combat Anemia in China
中国抗击贫血战略的绩效和CE支付
  • 批准号:
    8282715
  • 财政年份:
    2011
  • 资助金额:
    $ 62.84万
  • 项目类别:
The Causes and Behavioral Foundations of Mortality Decline in Developing Countrie
发展中国家死亡率下降的原因和行为基础
  • 批准号:
    7927023
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:
The Causes and Behavioral Foundations of Mortality Decline in Developing Countrie
发展中国家死亡率下降的原因和行为基础
  • 批准号:
    7429700
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:
The Causes and Behavioral Foundations of Mortality Decline in Developing Countrie
发展中国家死亡率下降的原因和行为基础
  • 批准号:
    7263495
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:
Women's Empowerment and Child Survival in the Historical United States
美国历史上的妇女赋权和儿童生存
  • 批准号:
    7189498
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:
The Causes and Behavioral Foundations of Mortality Decline in Developing Countrie
发展中国家死亡率下降的原因和行为基础
  • 批准号:
    7692253
  • 财政年份:
    2007
  • 资助金额:
    $ 62.84万
  • 项目类别:

相似国自然基金

基于构建骨骼类器官模型探究Fanconi anemia信号通路调控电刺激诱导神经化成骨过程的机制研究
  • 批准号:
    82302715
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FANCM蛋白在传统Fanconi anemia通路以外对保护基因组稳定性的功能
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
范可尼贫血(Fanconi Anemia)基因FANCM在复制后修复中的作用及FA癌症抑制通路的机制研究
  • 批准号:
    31200592
  • 批准年份:
    2012
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Investigation of crosstalk between Fanconi Anemia pathway and ATM for novel therapeutic strategies of chemoresistant ALT-positive high-risk neuroblastoma
范可尼贫血通路与 ATM 之间的串扰研究,用于化疗耐药 ALT 阳性高危神经母细胞瘤的新治疗策略
  • 批准号:
    24K10442
  • 财政年份:
    2024
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immune escape mechanisms in BCOR/BCORL1 mutant hematopoietic stem cells from patients with aplastic anemia
再生障碍性贫血患者 BCOR/BCORL1 突变型造血干细胞的免疫逃逸机制
  • 批准号:
    23K15297
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Fanconi anemia経路に着目したiPS細胞における高レベル複製ストレスの原因解明
阐明 iPS 细胞中高水平复制应激的原因,重点关注范可尼贫血途径
  • 批准号:
    23K14452
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Analysis of the mechanism of hemolytic anemia in canine babesiosis and development of novel therapeutic measures
犬巴贝斯虫病溶血性贫血机制分析及新治疗措施开发
  • 批准号:
    23KJ0074
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Mobile phone-based screening for anemia in young children in western Kenya
基于手机的肯尼亚西部幼儿贫血筛查
  • 批准号:
    10752968
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
Brain blood flow, oxygenation, and cognition in adult onset iron deficiency anemia
成人缺铁性贫血的脑血流量、氧合和认知
  • 批准号:
    10735765
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
Accuracy and Feasibility of Non-Invasive Anemia Screening Assistant (ASIST) Device in Resource-Limited Settings
资源有限环境中非侵入性贫血筛查辅助 (ASIST) 设备的准确性和可行性
  • 批准号:
    10575222
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
Liver-Gut Axis in Neonatal Anemia and Its Role in RBC Transfusion Associated Gut Injury
新生儿贫血中的肝肠轴及其在红细胞输注相关肠道损伤中的作用
  • 批准号:
    10583807
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
A Sample-to-Answer Point-of-Care Diagnostic for Recently Transfused Sickle Cell Anemia Patients in Low Resource Settings
针对资源匮乏地区最近输血的镰状细胞性贫血患者的从样本到答案的护理点诊断
  • 批准号:
    10564553
  • 财政年份:
    2023
  • 资助金额:
    $ 62.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了